2月14日, 南向资金增持中国生物制药1514.88万股。截止当日收盘,港股通共持有中国生物制药219449.10万股,占流通股11.67%。港股通增持金额前五个股分别为阿里巴巴-W、美团-W、工商银行、中芯国际、比亚迪电子。中国生物制药近5个交易日上涨8.75%,港股通累计增持1172.03万股;近20个交易日上涨12.15%,港股通累计减持660.91万股。|2月14日港股通(深)十大成交榜|...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.